Trovagene Inc (NASDAQ:TROV)

7.00
Delayed Data
As of Mar 27
 +0.23 / +3.40%
Today’s Change
2.97
Today|||52-Week Range
8.04
+62.79%
Year-to-Date

Today’s Trading

Previous close6.77
Today’s open6.72
Day’s range6.71 - 7.17
Volume233,583
Average volume (3 months)263,621
Market cap$168.9M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-26.32%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.01%
P/E ratioNM
Price/Sales290.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.38+5.69%
ERBERBA Diagnostics Inc-0.30-7.84%
TTHITransition Therapeut...-0.04-0.60%
TRILTrillium Therapeutic...+1.39+8.19%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$280.0K
Annual profit (last year)-$14.3M
Net profit margin-5,116.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account